glp-1 management digital health startups Four Strategies for Competing in the Crowded Obesity Drug Marketplace Technologies enabling long-term health outcomes

Key Takeaways GLP-1 microdosing is a rapidly growing practice that sits in a gray area between established medicine and emerging trend

Lancet 1(7897):1416

This could involve reading a book (a physical one, not on a screen), taking a warm bath, listening to soothing music, practicing deep breathing exercises, or engaging in light stretching

The prescribing of GLP-1 receptor agonists for women of reproductive age is increasing in Australia, and most prescriptions are for women not diagnosed with type 2 diabetes

There is also a conceptual shift underway

Ozempic is a brand-name prescription drug that the Food and Drug Administration (FDA) has approved for Type 2 diabetes, cardiovascular risk reduction, and kidney disease in adults